Kw. Park et al., COMPARATIVE ACTIVITIES OF NOVEL BETA-LACTAMASE INHIBITORS, 6-EXOMETHYLENE PENAMSULFONES (CH1240, CH2140) IN EXPERIMENTAL MOUSE INFECTION MODEL, Archives of pharmacal research, 21(5), 1998, pp. 527-530
The antibacterial activity oi novel p-lactamase inhibitors, 6-exomethy
lene penamsulfones (CH 1240, CH2140), has been compared in vivo with t
hat of sulbactam and clavulanic acid against p-lactamase producing str
ains, in vivo microbiological assessment was used as experimental mous
e infection model by gram negative strains. Against Pseudomonas aerugi
nosa F0013, cefoperazone/CH1240 was slightly less active than sulbacta
m. Ampicillin/CH 1240 was more active than sulbactam against Citrobact
er diversus species. That oi ampicillin/CH 2140 was less effective tha
n sulbactam against Escheriachia coli 3457. Especially against Citroba
cter diversus 2046E, amoxicillin/CH 2140 was the most potent and amoxi
cillin/CH1240 was slightly more active than clavulanic acid. Consequen
tly the difference in efficacy between the drug combinations appears t
o be related to the degree oi protection afforded the animals by the P
lactamase inhibitors. CH1240 and CH2140 are promising new agents and s
hould undergo further investigations.